文献速递关节外科骨质疏松与代谢性骨病

代谢综合征及其组分对全髋关节置换术后患者报告结局的影响

Does the Presence of Metabolic Syndrome or Its Components Influence Patient-Reported Outcomes After Total Hip Arthroplasty?
PubMed 文献 · J Arthroplasty · 2026-04-09

这项前瞻性队列研究纳入514例因髋骨关节炎行初次全髋关节置换术的患者,按有无代谢综合征分为455例与59例两组。术后一年,代谢综合征组髋功能多个子项评分更差,抑郁和焦虑黄旗比例更高(13.6% vs 4.0%,P=0.006),血脂异常与较差结局相关。

要点

  • 代谢综合征与全髋关节置换术后一年髋功能及心理结局受损相关。
  • 血脂异常是代谢综合征组分中与较差结局尤其相关的因素。
  • 术后一年代谢综合征组抑郁和焦虑黄旗比例显著高于无代谢综合征组。

核心结论

  • 代谢综合征与全髋关节置换术后功能和心理结局受损相关,血脂异常是尤其相关的 contributing 组分。

研究设计与样本

  • 前瞻性队列研究,纳入514例因髋骨关节炎在大学医院行初次全髋关节置换术的患者。
  • 按有无代谢综合征分层:无代谢综合征455例,有代谢综合征59例。
  • 患者报告结局指标于术前、术后一个月和术后一年评估,包括髋功能、疼痛、生活质量和心理健康。

主要发现

  • 术后一年,代谢综合征组髋功能多个子项评分更差。
  • 代谢综合征各组分对髋功能影响不同:血脂异常与较差结局相关,肥胖、2型糖尿病和高血压的影响有限。
  • 术前代谢综合征组与无代谢综合征组抑郁和焦虑黄旗比例无差异,术后一年代谢综合征组比例更高(13.6% vs 4.0%,P=0.006)。

关键数值与推荐

  • 术后一年抑郁和焦虑黄旗比例:代谢综合征组13.6%,无代谢综合征组4.0%,P=0.006。

临床怎么用

  • 术前评估应整合代谢风险分析与心理健康筛查及优化,以改善全髋关节置换术患者结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An increasing number of individuals who suffer from hip osteoarthritis (OA) undergoing total hip arthroplasty (THA) have metabolic comorbidities. Among these, metabolic syndrome (MetS) has been identified as a potential key contributor to OA pathogenesis. Although MetS is also known to increase perioperative risks, its impact on treatment outcomes remains poorly understood. We conducted a prospective cohort study aimed at evaluating whether the presence of MetS and its individual components influences postoperative hip function, health-related quality of life, and mental health outcomes following THA. METHODS: This prospective cohort study included 514 patients who underwent primary THA for hip OA at our university hospital. Patients were stratified into two groups based on the absence (n = 455) or presence (n = 59) of MetS. Patient-reported outcome measures were assessed preoperatively and at one month and one year postoperatively, including hip function, pain , quality of life, and mental health. RESULTS: At one year postoperatively, patients who were diagnosed with MetS exhibited worse scores regarding hip function in several subcategories. Differential effects of the individual MetS components regarding hip function were observed. Dyslipidemia was associated with poorer outcomes, whereas the effects of obesity, T2DM, and hypertension were limited. Importantly, while the proportion of patients reporting yellow flags for depression and anxiety did not differ preoperatively between patients who did and did not have MetS, a higher prevalence was observed in the MetS group at one year postoperatively (MetS: 13.6% versus No MetS: 4.0%, P = 0.006). CONCLUSIONS: We demonstrated that MetS is associated with impaired functional and psychological outcomes after THA, with dyslipidemia as a particularly relevant contributing component. Our findings highlight the importance of an integrated preoperative assessment that combines metabolic risk profiling with mental health screening and optimization to enhance patient outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Goedecke E, Alimy AR, Ocokoljic A, et al. Does the Presence of Metabolic Syndrome or Its Components Influence Patient-Reported Outcomes After Total Hip Arthroplasty? J Arthroplasty. 2026. PMID: 41966422. doi:10.1016/j.arth.2026.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。